FDA Approval Letter of Colorado’s Drug Importation Program

On June 16, 2026, the U.S. Food and Drug Administration (FDA) sent this letter of authorization for Colorado's Section 804 Importation Program (SIP). This SIP is a state-led initiative authorized by the FDA to import selected, lower-cost prescription drugs from Canada . . .